Hamill-Skoch Sarah, Hicks Paul, Prieto-Hicks Ximena
Department of Psychiatry, University of Arizona, Tuscon, AZ, USA.
Department of Family and Community Medicine, University of Arizona, Tuscon, AZ, USA.
Adolesc Health Med Ther. 2012 Sep 10;3:95-104. doi: 10.2147/AHMT.S13781. eCollection 2012.
Major depressive disorder often begins in adolescence, is chronic and recurrent, and heightens an individual's risk for major depressive disorder in adulthood. Treatment-resistant depression is a problem for a significant minority of adolescents. Few studies have examined treatments for treatment-resistant depression among adolescents, and even fewer have examined the use of cognitive-behavioral therapy as a monotherapy or in combination with pharmacological treatments. Mental health professionals have a strong interest in understanding what treatments are appropriate for adolescents who are treatment resistant. Preliminary evidence from current published trials indicates that the use of cognitive-behavioral therapy in combination with antidepressant medication yields the best outcome for treatment-resistant depression in adolescents. Secondary analyses also suggest that the utility of cognitive behavioral therapy can be increased by ensuring adolescents receive a therapeutic dose of treatment sessions (more than nine sessions) and the inclusion of two treatment components: social skills and problem solving training. Guidelines for clinicians as well as areas for future research are discussed.
重度抑郁症通常始于青春期,具有慢性和复发性,会增加个体成年后患重度抑郁症的风险。难治性抑郁症是相当一部分青少年面临的问题。很少有研究探讨青少年难治性抑郁症的治疗方法,更少有人研究将认知行为疗法作为单一疗法或与药物治疗联合使用的情况。心理健康专业人员非常希望了解哪些治疗方法适合难治性青少年。当前已发表试验的初步证据表明,认知行为疗法与抗抑郁药物联合使用对青少年难治性抑郁症的治疗效果最佳。二次分析还表明,通过确保青少年接受治疗性剂量的治疗疗程(超过九个疗程)以及纳入两个治疗组成部分:社交技能和解决问题训练,可以提高认知行为疗法的效用。文中还讨论了针对临床医生的指导方针以及未来的研究方向。